# Low Molecular Weight hEparin vs. Aspirin Post-partum

> **NCT05058924** · NA · COMPLETED · sponsor: **Mount Sinai Hospital, Canada** · enrollment: 30 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** Prophylactic low molecular weight heparin
- **DRUG:** Low molecular weight heparin and low-dose aspirin

## Key facts

- **NCT ID:** NCT05058924
- **Lead sponsor:** Mount Sinai Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-29
- **Primary completion:** 2024-02-29
- **Final completion:** 2024-03-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05058924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05058924, "Low Molecular Weight hEparin vs. Aspirin Post-partum". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05058924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*